Dysfunction of the episodic memory network in the Alzheimer's disease cascade
Lattmann-Grefe, R.; Vockert, N.; Machts, J.; Suksangkharn, Y.; Yakupov, R.; Schuetze, H.; Glanz, W.; Incesoy, E.; Butryn, M.; Luesebrink, F.; Schmid, M.; Stark, M.; Kleineidam, L.; Spottke, A.; Coenjaerts, M.; Brosseron, F.; Fliessbach, K.; Schneider, A.; Dechent, P.; Hetzer, S.; Scheffler, K.; Ramirez, A.; Laske, C.; Sodenkamp, S.; Altenstein, S.; Schneider, L.-S.; Gref, D.; Spruth, E. J.; Lohse, A.; Schott, B. H.; Wiltfang, J.; Kilimann, I.; Goerss, D.; Rostamzadeh, A.; Priller, J.; Peters, O.; Hellmann-Regen, J.; Teipel, S.; Jessen, F.; Maass, A.; Ziegler, G.; Duezel, E.
Show abstract
Alzheimers disease (AD) is a major cause of dementia and cognitive decline. Here we assessed how episodic memory circuit dysfunction, a hallmark of AD, is related to the longitudinal cascade of AD biomarkers, neurodegeneration and cognition using data from the DZNE Longitudinal Cognitive Impairment and Dementia study. This data set is unique by including over 1000 longitudinal functional magnetic resonance imaging (fMRI) measurements during episodic memory encoding. We leveraged a disease progression model (DPM) to obtain AD progression scores. Voxel-wise analyses revealed widespread loss of deactivation (hyperactivation) and activation (hypoactivation) with increasing disease stage. Hyperactivation trajectories were nonlinear and visually preceded trajectories of cognition. Overall, hyperactivation was independently associated with co-occurrence of amyloid- and tau-positivity and neurodegeneration, suggesting synaptic dysfunction and neurodegeneration as two independent drives of cognitive decline. Our results therefore provide evidence for a critical time window in which pharmacological treatments targeting the synapse may improve cognition.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Default mode network tau predicts future clinical decline in atypical early Alzheimer’s disease 98%
- Glucose metabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease 98%
- Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome 98%
Similar papers in this journal
- Cognitive Reserve Against Alzheimer's Pathology Is Linked to Brain Activity During Memory Formation 98%
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 98%
- Hemispheric Asymmetry of Tau Pathology is Related to Asymmetric Amyloid Deposition in Alzheimer's Disease 97%
Similar papers in this journal
- Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease 98%
- Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults 97%
- Tau-PET and in vivo Braak-staging as a prognostic marker in Alzheimer’s disease 97%
Similar papers in this journal
- Detecting the effect of genetic diversity on brain composition in an Alzheimer's disease mouse model 94%
- Mitochondrial bioenergetic signatures differentiate asymptomatic from symptomatic Alzheimer's disease 93%
- Improving genetic risk modeling of dementia from real-world data in underrepresented populations 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.